false 0001530766 0001530766 2023-11-30 2023-11-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 30, 2023

 

BioSig Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38659   26-4333375
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

55 Greens Farms Road, 1st Floor

Westport, Connecticut

   06880
(Address of principal executive offices)   (Zip Code)

 

(203) 409-5444

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
Common Stock, par value $0.001 per share   BSGM   The NASDAQ Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective as of November 30, 2023 (the “Grant Date”), the board of directors (the “Board”) of BioSig Technologies, Inc. (the “Company”) granted awards of restricted stock pursuant to the Company’s 2023 Long-Term Incentive Plan (the “Plan”) to certain named executive officers of the Company in connection with a temporary reduction of 30% of their salaries.

 

The Board granted to (i) Kenneth L. Londoner, Chief Executive Officer of the Company, 219,700 restricted shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (ii) John R. Sieckhaus, Chief Operating Officer of the Company, 92,300 restricted shares of Common Stock (collectively, the “RSAs”), subject to the terms and conditions of the Company’s Plan and the Company’s standard Restricted Stock Award Agreement. The RSAs fully vested on the Grant Date.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BIOSIG TECHNOLOGIES, INC.
     
Date: December 5, 2023 By: /s/ Kenneth L. Londoner
  Name: Kenneth L. Londoner
  Title: Executive Chairman

 

 

 

v3.23.3
Cover
Nov. 30, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 30, 2023
Entity File Number 001-38659
Entity Registrant Name BioSig Technologies, Inc.
Entity Central Index Key 0001530766
Entity Tax Identification Number 26-4333375
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 55 Greens Farms Road
Entity Address, Address Line Two 1st Floor
Entity Address, City or Town Westport
Entity Address, State or Province CT
Entity Address, Postal Zip Code 06880
City Area Code (203)
Local Phone Number 409-5444
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol BSGM
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
BioSig Technologies (NASDAQ:BSGM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more BioSig Technologies Charts.
BioSig Technologies (NASDAQ:BSGM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more BioSig Technologies Charts.